Why This Matters
Clinical and regulatory catalysts can define valuation, financing options, and investor attention for small-cap biotechnology companies.
Phase 1 Readouts
Phase 1 Readouts are among the catalyst types tracked across undercovered healthcare companies. This public page focuses on timing, company, asset, and broad confidence labels.
| Company | Ticker | Catalyst | Timing | Asset | Confidence |
|---|---|---|---|---|---|
| Mustang Bio Inc | MBIO | Clinical Trial Completion | 2026-08-06 | cyclophosphamide | Low |
| Boundless Bio Inc | BOLD | Clinical Trial Completion | 2026-09-30 | BBI-355 | Low |
| MetaVia Inc | MTVA | Clinical Trial Completion | 2026-11-09 | DA-1726 | Low |
| BioCardia Inc | BCDA | Clinical Trial Completion | 2026-12 | CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs) | Low |
| Serina Therapeutics Inc | SER | Clinical Trial Completion | 2026-12-08 | mRNA-1645-eODGT8 | Low |
| 60 Degrees Pharmaceuticals Inc | SXTP | Clinical Trial Completion | 2026-12-08 | mRNA-1645-eODGT8 | Low |
| Actinium Pharmaceuticals Inc | ATNM | Clinical Trial Completion | 2026-12-31 | Actinium Ac 225 DOTATATE RYZ101 | Low |
| CalciMedica Inc | CALC | Clinical Trial Completion | 2027-01 | CM4620 | Low |
| IN8bio Inc | INAB | Clinical Trial Completion | 2027-01 | EAGD T-cell infusion (Phase I) | Low |
| Azitra Inc | AZTR | Clinical Trial Completion | 2027-01-15 | ATR04-484 | Low |
| Apollomics Inc | APLM | Clinical Trial Completion | 2027-01-31 | APL-101 | Low |
| Creative Medical Technology Holdings Inc | CELZ | Clinical Trial Completion | 2027-01-31 | CELZ-201 Administration | Low |
| Xilio Therapeutics Inc | XLO | Clinical Trial Completion | 2027-02 | XTX301 | Low |
| Lantern Pharma Inc | LTRN | Clinical Trial Completion | 2027-02-01 | STAR-001 (LP-184) will be administered via IV infusion over 30 (± 5) minutes on Day 1 and Day 8 of each 21-day cycle. | Low |
| Taysha Gene Therapies | TSHA | Clinical Trial Completion | 2027-03-12 | TSHA-101 | Low |
| 60 Degrees Pharmaceuticals Inc | SXTP | Clinical Trial Completion | 2027-04-01 | NPX372 | Low |
| Telomir Pharmaceuticals Inc | TELO | Clinical Trial Completion | 2027-05 | Zn-Telomir | Low |
| Cns Pharmaceuticals Inc | CNSP | Clinical Trial Completion | 2027-06 | Xevinapant | Low |
| Sensei Biotherapeutics Inc | SNSE | Clinical Trial Completion | 2027-06 | SNS-101 (anti-VISTA) | Low |